IPF treatment SM001-055 was generally safe and improved lung function, according to top-line data from a Phase 2a trial.

Columnist Charlene Marshall was confused when her latest pulmonary function test results didn't seem to reflect how she was feeling.

Post-transplant, columnist Sam Kirton avoids negativity at all costs, as it's detrimental to his mental health and overall well-being.

Many factors helped columnist Sam Kirton know when it was time to stop working so he could better attend to his health issues with IPF.

Sam Kirton started his column in November 2021 and writes from his home at Lake Anna, Virginia, where he lives with his wife Susan. His diagnosis at age 59 with idiopathic pulmonary fibrosis in ...

Insilico Medicine’s ISM001-055 was generally safe and improved lung function in people with idiopathic pulmonary fibrosis (IPF), according to top-line data from a Phase 2a trial. The trial ...

A Phase 3 clinical trial testing Boehringer Ingelheim’s oral investigational treatment nerandomilast in people with idiopathic pulmonary fibrosis (IPF) has met its primary goal of demonstrating the ...

I do not typically use my columns as a platform to complain about my idiopathic pulmonary fibrosis (IPF). Usually, I try to inform or inspire others; however, that’s not always possible with this ...